The accuracy of FibroScan, FIB-4, and nonalcoholic fatty liver disease fibrosis score in predicting...
Read More
8th APP, Nursing and Primary Care Liver Conference Saturday, February 1, 2025 Embassy Suites...
Spotlight on ARC: Advancing Clinical Research Excellence • Liver Spot • Hepatitis C Elimination...
Key Takeaways The phase 2 study of a bemnifosbuvir and ruzasvir regimen for the...
Fabian Rodas Ochoa, MD, transplant hepatologist and clinical assistant professor of medicine at UT...
This edition includes: • REZDIFFRA™ (Resmetirom): A New Hope for Patients with Advanced Fibrosis in...
Survodutide has an “acceptable safety profile” in patients with metabolic dysfunction-associated steatohepatitis with compensated and decompensated cirrhosis,...
